Blue Horseshoe Stocks: PZOO News & Other Updates

Pazoo, Inc. PZOO

We directed our attention at PZOO to start off the week, and so far the stock has put on a good performance. From a low of a penny on Monday we saw a nice move up, and yesterday the stock continued to build a higher base of support.

We witnessed a trading range from .0131 to .0144, a modest 10% intraday move; from our observed low on Monday, that’s registered as a nice 44% intraweek swing.

We’re going to need to keep our eye on PZOO as the week progresses, especially in light of the important news update we received from the company this morning regarding its ongoing expansion into the marijuana testing business (excerpt below).

WHIPPANY, N.J., May 20, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (OTC:PZOO), is pleased to announce that wholly-owned subsidiary Harris Lee has gained the exclusive right to operate testing laboratories in the State of Colorado utilizing Steep Hill Labs’ highly-rated testing techniques and methodology.

Colorado is the third state in which Pazoo Inc. subsidiaries have created a license relationship with Steep Hill for their testing technology. Agreements have been established with Steep Hill in Nevada, Oregon and now Colorado. >> FULL PR


PlasmaTech Biopharmaceuticals, Inc. PTBI

PTBI is another call we made on Monday which has also returned a noteworthy two-day performance. It’s one that we had already tracked  over an impressive range earlier this month, and when we rehashed it on Monday, we observed a low of 8.05.

Yesterday the stock pushed its way to a high of 10.83, marking a 35% swing. We want to continue to keep a keen eye on PTBI; this morning’s PR alludes to the granting of Orphan Drug status to a couple of the company’s products by the FDA:


NOHO, Inc. DRNK

DRNK also appeared in yesterday’s premarket report, and we wanted to mention the activity that ensued. After gapping up in the morning, the stock executed a dip-and-rip pattern, coming down to bounce off of a low of .0054 before running back to .0076, providing a chance at up to 41% in intraday gains.

Enviro-Serv, Inc. EVSV

We mentioned EVSV along with MNKD yesterday, and it too made a strong move on the day. From .001 the stock found a subsequent high of .0015 for a nice, round, 50% pop.


Side Note:

We’re going to have an eye on HIHI as well today on the heel of some share reduction news. The company is reducing the outstanding shares by nearly a third, so we’ll be interested to follow the resulting price action. >> VIEW PR


Extended Watchlist:
PBMD, ISR, GNCA, PBY, AVEO

Blue Horseshoe Stocks: CYBR, MCP, MEIP & More

CyberArk Software, Ltd. CYBR

Our first experiences with CYBR were good ones, when we successfully called a couple of potentially lucrative options trades around the middle of last month. It was in our report from February 13ththat we targeted CYBR $50 and $55 Calls, and that day we saw moves in those contracts of 72% and 165% respectively.
We flagged CYBR once again yesterday, which had previously been under several weeks of consolidation, yet was gapping up in the premarket. The stock did well in reversing its path, trading in a range from 50.79-55.03, and holding the majority of those gains into the close.

Our current options idea is going to be the 04/17 $50 Calls (Closed at 6.60 yesterday). Should CYBR reach its way back to the $60-level anytime in the next few weeks, the gains we see in those contracts will be quite substantial.


Molycorp, Inc. MCP

MCP appeared in yesterday’s extended watchlist and demonstrated a reversal of its own. We’re going to place MCP on more intensive watch as the week progresses, as it has the markings of a potential bottom play.

We’ve illustrated some of the key characteristics of the chart below, which appears to be gearing up for what could be a big swing. The stock ran well over a dollar at the beginning of last month, so the potential for rapid gains has certainly been demonstrated.


MEI Pharma, Inc. MEIP

We’ve also got an eye on MEIP after the stock was crushed down to a 52-week low yesterday, following the company’s announcement of the failure of its cancer drug in middle-stage testing.

A single-session depreciation on the order of 70% is the hallmark of one heck of a knee-jerk reaction, and the stock appears to be gapping up slightly this morning, so we’ll be on the lookout for a recovery in MEIP shares in coming days.


Extended Watchlist:
IMGN, ATOS ISR, HEB, GEVO, NEPT

Blue Horseshoe Stocks: Mid-Week Review

Direxion Daily Jr Gld Mnrs Bear 3X ETF (JDST)

Yesterday marked the third consecutive day that we had been tracking the JDST ETF, and the third consecutive session that we witnessed a northerly move. From an early low of 14.07, it would go on to attain a daily high of 17.42 on volume that exceeded the 3-month average by nearly 2M shares. That worked out to a solid intraday run of 24%

As measured from the low we observed following our initial alert on Friday morning (11.40) to yesterday’s peak PPS, the JDST has risen 53% overall.

As we’ve previously mentioned, due to the nature of the fund, extended success for the JDST is contingent upon continued hardship for gold, which continued to flirt with its 3-month lows yesterday.


Side Note:

By now, our regular readers are aware of our trading chatrooms*, which have have turned up prime opportunities in the past due to reader participation. Yesterday, we were treated to an excellent idea from ‘Tango’ in the form of PPCH:

Following this exchange, PPCH traded in a monstrous range from .006-.035, a 483% intraday rip!

Incidentally the company also has news out this morning:

MELBOURNE, Australia, March 11, 2015 /PRNewswire/ — Propanc Health Group Corporation (PPCH) (“Propanc” or “the Company”), an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced fresh new insights have emerged into the development and spread of carcinomas >> FULL PR

*Remember, any readers who’d like to get involved in our trading chats in the future can do so easily! For either the Premium or the free chats, simply add “stocksumo” as a contact on Skype and request access!


Extended Watchlist:
BLRX, ARCP, CYTX, ISR